These effects vary among individuals
These findings suggest that the addition of SGLT2is does not modify the overall benefit-risk profile of GLP-1RAs, including semaglutide, when used in patients with CKD[73]
Going from 2.4 mg back to 1.7 mg, for instance, often provides significant side effect relief while maintaining most of the weight loss benefit
[1] [3] There is no established pharmacological mechanism by which semaglutide would directly cause gastrointestinal bleeding, based on current evidence
You get a molecule that resembles the active peptide but does not function like it
Immediate, low-risk tactics can help, for example, a brisk 5 to 10-minute walk after meals, slow, deep chewing, or targeted OTC aids like simethicone or lactase for specific situations